{
 "page": "https://omnirx.org/conditions/renal-cell-carcinoma/axitinib",
 "edition": "2026-11",
 "editionRoot": "006ab9a329709cbe",
 "license": "https://omnirx.org/license",
 "generated": "2026-11-11",
 "condition": {
  "id": "renal-cell-carcinoma",
  "name": "Renal Cell Carcinoma"
 },
 "drug": {
  "ingredient": "Axitinib",
  "brands": [
   "Inlyta"
  ]
 },
 "orderIsRanking": false,
 "orderNote": "Fixed order: the FDA label, public Medicare facts, the manufacturer, charities, research access. It is not a ranking and no saving is computed.",
 "routes": [
  {
   "id": "label",
   "title": "Why this drug and this condition are paired",
   "found": true,
   "quote": "in combination with avelumab, for the first-line treatment of patients with advanced renal cell carcinoma (RCC).",
   "context": "indication",
   "source": "https://api.fda.gov/drug/label.json?search=set_id:%2284137882-e000-47da-bd5b-fa76ab3c76f9%22&limit=1",
   "readOn": "2026-11-10",
   "fact_id": "09f53e6003cb9b3ea3324b07"
  },
  {
   "id": "part-d",
   "title": "Medicare Part D: the yearly out-of-pocket threshold",
   "found": true,
   "text": "$2,400 in 2027 ($2,100 in 2026)",
   "source": "https://www.cms.gov/files/document/2027-announcement.pdf",
   "readOn": "2026-11-08"
  },
  {
   "id": "price",
   "title": "Medicare negotiated price",
   "found": false,
   "usd30DaySupply": null,
   "effective": null,
   "source": null,
   "readOn": null
  },
  {
   "id": "program",
   "title": "Manufacturer and foundation programs",
   "found": true,
   "programs": [
    {
     "name": "Pfizer RxPathways (Pfizer Patient Assistance Program)",
     "url": "https://omnirx.org/assistance/pfizer-rxpathways",
     "programPageIsExternal": false,
     "inCurrentList": true,
     "note": null,
     "listKind": "products remaining within Pfizer PAP as of January 1, 2026",
     "status": null,
     "statusRead": null,
     "fact_id": "f85cda8f88783ee80deca94f"
    }
   ]
  },
  {
   "id": "funds",
   "title": "Charitable funds for Renal Cell Carcinoma",
   "found": true,
   "fundsHeld": 4,
   "open": 1,
   "readOn": "2026-11-08",
   "openFunds": [
    {
     "name": "Renal Cell Carcinoma - Medicare Access",
     "org": "HealthWell Foundation"
    }
   ],
   "hubUrl": "https://omnirx.org/conditions/renal-cell-carcinoma"
  },
  {
   "id": "trials",
   "title": "Clinical trial access",
   "found": false,
   "recruitingInterventionalTrials": null,
   "source": null,
   "readOn": null,
   "fact_id": null
  }
 ]
}